Published in J Pharm Policy Pract on January 31, 2015
Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study. J Pharm Policy Pract (2015) 0.83
'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. J Pharm Policy Pract (2016) 0.78
'Doing' health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan (2008) 4.81
Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ (2000) 4.19
Private health care in developing countries. BMJ (2001) 2.89
Formulation of medicines for children. Br J Clin Pharmacol (2005) 1.63
Evidence based medicine: increasing, not dictating, choice. BMJ (2007) 1.60
Concept of essential medicines and rational use in public health. Indian J Community Med (2010) 1.28
The status of paediatric medicines initiatives around the world--What has happened and what has not? Eur J Clin Pharmacol (2011) 1.26
Whose policy is it anyway? International and national influences on health policy development in Uganda. Health Policy Plan (1995) 1.23
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys. PLoS Med (2014) 1.12
Pediatric drug formulations: challenges and potential solutions. Ann Pharmacother (1999) 1.09
Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study. PLoS One (2013) 1.01
Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Parasitology (2011) 0.98
A research agenda to promote affordable and quality assured medicines. J Pharm Policy Pract (2014) 0.96
Pediatric formulations: international issues and potential solutions. Paediatr Drugs (2009) 0.95
Pediatric drugs--a review of commercially available oral formulations. J Pharm Sci (2008) 0.95
Cotrimoxazole resistance of Streptococcus pneumoniae and commensal streptococci from Kampala, Uganda. Scand J Infect Dis (2009) 0.94
Pediatric therapeutics and medicine administration in resource-poor settings: a review of barriers and an agenda for interdisciplinary approaches to improving outcomes. Soc Sci Med (2009) 0.93
Providing safe medicines for children in Nigeria: The impediments and remedies. Ann Afr Med (2010) 0.92
Intestinal schistosomiasis among preschool children along the shores of Lake Victoria in Uganda. Acta Trop (2014) 0.85
Essential medicines for children: Should we focus on a priority list of medicines for the present? J Pharmacol Pharmacother (2011) 0.84
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups. Clin Ther (2008) 0.81
Children's medicines in Tanzania: a national survey of administration practices and preferences. PLoS One (2013) 0.81
Understanding low uptake of mass treatment for intestinal schistosomiasis among school children: a qualitative study in Jinja district, Uganda. J Biosoc Sci (2014) 0.79
Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit! J Pharm Policy Pract (2013) 0.78
Explaining the slow transition of child-appropriate dosage formulations from the global to national level in the context of Uganda: a qualitative study. J Pharm Policy Pract (2015) 0.83
Availability and utilization of the WHO recommended priority lifesaving medicines for under five-year old children in public health facilities in Uganda: a cross-sectional survey. J Pharm Policy Pract (2015) 0.82
'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. J Pharm Policy Pract (2016) 0.78